Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8988751 | The Veterinary Journal | 2005 | 6 Pages |
Abstract
After IV administration, the plasma concentration was characteristic of a two-compartment open model. The main pharmacokinetic variables were: t1/2λn=82.5min, MRT = 90.1 min, Vdarea = 0.81 L/kg and Clb = 3.9 mL/kg/min. After single oral administration the main pharmacokinetic variables were: Cmax = 758 μg/L, tmax = 347 min and Clb/f = 3.7 mL/kg/min for Amx-FP. The oral bioavailability (F) was calculated at 11% for Amx-FP. Based on maximum residue levels (MRL) for AMX in pigs established at 50 μg/kg for all tissues, the withdrawal times of AMX in muscle and skin plus fat were estimated (95% tolerance limit and 95% confidence) to fall below the MRL after a withdrawal period of seven days. Levels of AMX in the liver and kidneys were estimated to fall below the MRL after a withdrawal period of four days.
Related Topics
Life Sciences
Agricultural and Biological Sciences
Animal Science and Zoology
Authors
Esther Hernandez, Raquel Rey, Mariona Puig, Maria Angeles Garcia, Carlos Solans, Miguel Angel Bregante,